PRLD
Prelude Therapeutics Inc

1,129
Mkt Cap
$188.38M
Volume
339,141.00
52W High
$4.22
52W Low
$0.6101
PE Ratio
-2.21
PRLD Fundamentals
Price
$2.99
Prev Close
$3.19
Open
$3.15
50D MA
$2.54
Beta
1.85
Avg. Volume
353,143.37
EPS (Annual)
-$1.29
P/B
2.74
Rev/Employee
$153,670.89
$137.75
Loading...
Loading...
News
all
press releases
Prelude Therapeutics (NASDAQ:PRLD) Price Target Raised to $6.00 at Citizens Jmp
Citizens Jmp lifted their price target on shares of Prelude Therapeutics from $3.00 to $6.00 and gave the stock a "market outperform" rating in a report on Wednesday...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Prelude Therapeutics Earnings Report: Q4 Overview
read more...
Benzinga·12d ago
News Placeholder
Prelude Therapeutics (PRLD) Expected to Announce Earnings on Monday
Prelude Therapeutics (NASDAQ:PRLD) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...
MarketBeat·20d ago
News Placeholder
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Short Interest Update
Prelude Therapeutics Incorporated (NASDAQ:PRLD - Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 30th, there was short interest...
MarketBeat·1mo ago
News Placeholder
Prelude Therapeutics (NASDAQ:PRLD) Trading Down 0.9% - Should You Sell?
Prelude Therapeutics (NASDAQ:PRLD) Stock Price Down 0.9% - What's Next...
MarketBeat·1mo ago
News Placeholder
Why Did PRLD Stock Surge 13% Today?
Prelude Therapeutics said on Tuesday that the FDA gave clearances to proceed with early-stage trials for its experimental drug PRT12396.
Stocktwits·2mo ago
News Placeholder
Prelude Therapeutics (NASDAQ:PRLD) Rating Lowered to Hold at Wall Street Zen
Wall Street Zen cut Prelude Therapeutics from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat·2mo ago
News Placeholder
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Short Interest Up 28.5% in December
Prelude Therapeutics Incorporated (NASDAQ:PRLD - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest...
MarketBeat·3mo ago
News Placeholder
Prelude Therapeutics (NASDAQ:PRLD) Stock Price Up 2.1% - What's Next?
Prelude Therapeutics (NASDAQ:PRLD) Trading 2.1% Higher - Time to Buy...
MarketBeat·3mo ago
News Placeholder
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
GS stands out as Zacks showcases how its stock picks like MU and PRLD delivered strong gains despite a shaky market.
Zacks·4mo ago
<
1
2
...
>

Latest PRLD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.